Q. Xiu

发表

Bronchial Smooth Muscle Proliferation and B Pathways , Causing κ ERK ) and NF-Bronchial Epithelium via MAPK ( JNK and YKL-40 Induces IL-8 Expression from

B. Li, Hao Tang, Yu Sun, 2012 .

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.

Jun Ma, Yi-long Wu, Q. Xiu, 2011, The Lancet. Oncology.

Real-life effectiveness of budesonide/formoterol therapy in asthma: A subanalysis of the SMARTASIA study.

N. Zhong, Q. Xiu, Kewu Huang, 2016, Allergy and asthma proceedings.

β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis.

Bing Li, Q. Xiu, W. Nie, 2014, The Journal of antimicrobial chemotherapy.

Effects of Polymorphisms -1112C/T and +2044A/G in Interleukin-13 Gene on Asthma Risk: A Meta-Analysis

Q. Xiu, B. Li, Jiarong Bian, 2013, PloS one.

Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease

Hao Tang, Zheng Fang, Q. Xiu, 2015, Lung.

A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia.

Q. Xiu, Heping Yang, Chengping Hu, 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease

N. Zhong, Jinping Zheng, Q. Xiu, 2012, Current medical research and opinion.

Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis

Q. Xiu, W. Nie, Yi Zhang, 2012, PloS one.

Overall survival (OS) results from OPTIMAL (CTONG0802), a phase III trial of erlotinib (E) versus carboplatin plus gemcitabine (GC) as first-line treatment for Chinese patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC).

Yi-long Wu, Q. Xiu, Chengping Hu, 2012 .

Cytotoxic T-Lymphocyte Associated Antigen 4 Polymorphisms and Asthma Risk: A Meta-Analysis

Ji-quan Chen, Q. Xiu, W. Nie, 2012, PLoS ONE.

Interferon-gamma +874A/T polymorphism is associated with asthma risk: a meta-analysis.

Q. Xiu, W. Nie, L. Meng, 2014, Journal of investigational allergology & clinical immunology.

Interferon-g + 874 A / T Polymorphism Is Associated With Asthma Risk : A Meta-analysis

Q. Xiu, X. Wang, W. Nie, 2014 .

The interleukin-4 − 589 C / T polymorphism and the risk of asthma : A meta-analysis including 7345 cases and 7819 controls

Q. Xiu, Zhaoqin Zhu, W. Nie, 2013 .

Rosai-Dorfman disease of multiple organs, including the epicardium: An unusual case with poor prognosis.

B. Li, Hao Tang, Ji-quan Chen, 2011, Heart & lung : the journal of critical care.

Association between CC motif chemokine ligand 5 (CCL5) polymorphisms and asthma risk: an updated meta-analysis.

Q. Xiu, W. Nie, Y. Zang, 2015, Journal of investigational allergology & clinical immunology.

Effects of TNF-α polymorphisms on asthma risk: a systematic review and meta-analysis.

Q. Xiu, W. Nie, Y. Zang, 2014, Journal of investigational allergology & clinical immunology.

Secretoglobin 1A member 1 (SCGB1A1) +38A/G polymorphism is associated with asthma risk: a meta-analysis.

Ji-quan Chen, Q. Xiu, W. Nie, 2013, Gene.

The interleukin-4 -589C/T polymorphism and the risk of asthma: a meta-analysis including 7,345 cases and 7,819 controls.

Q. Xiu, Zhaoqin Zhu, W. Nie, 2013, Gene.

Association between Interleukin-4 Receptor α Chain (IL4RA) I50V and Q551R Polymorphisms and Asthma Risk: An Update Meta-Analysis

Ji-quan Chen, Q. Xiu, W. Nie, 2013, PloS one.

Angiotensin-converting enzyme I/D polymorphism is associated with pneumonia risk: A meta-analysis

Lin Xiao, Ji-quan Chen, Q. Xiu, 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Efficacy and Safety of Inhalation of Budesonide/Formoterol via Turbuhaler® in Chinese Patients With Chronic Obstructive Pulmonary Diseas

N. Zhong, Jinping Zheng, Q. Xiu, 2011 .

b-Lactam / macrolide dual therapy versus b-lactam monotherapy for the treatment of community-acquired pneumonia in adults : a systematic review and meta-analysis

Q. Xiu, W. Nie, Bing Li, 2014 .

A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections

Yonghong Xiao, C. Bai, Q. Xiu, 2010, Chemotherapy.

Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population

B. Cao, Q. Xiu, Lan Yang, 2009, BMC infectious diseases.

UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer

Lei Jiang, Ji-quan Chen, Q. Xiu, 2012, Journal of Cancer Research and Clinical Oncology.

Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802).

Y. Wu, Y. Luo, Q. Xiu, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

YKL-40 Induces IL-8 Expression from Bronchial Epithelium via MAPK (JNK and ERK) and NF-κB Pathways, Causing Bronchial Smooth Muscle Proliferation and Migration

Hao Tang, Yu Sun, Zhao-quan Shi, 2012, The Journal of Immunology.

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer.

M. Ahn, Yuh-Min Chen, J. Yang, 2012, Lung cancer.

TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls

Ji-quan Chen, Q. Xiu, W. Nie, 2014, Tumor Biology.

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

Ying Cheng, B. Han, He-long Zhang, 2016, BMC Cancer.

YKL-40-mediated interleukin 8 production may be closely associated with remodeling of bronchial smooth muscle cells.

Hao Tang, Yu Sun, Zhao-quan Shi, 2012, American journal of respiratory and critical care medicine.

Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer

Hai Huang, Q. Xiu, Midie Xu, 2015, Laboratory Investigation.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer

Yang Zhang, C. Bai, B. Han, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Hydrogenase: the next antibiotic target?

Hao Tang, Zheng Fang, Ji-quan Chen, 2012, Clinical science.

B and T Lymphocyte Attenuator is a Target of miR-155 during Naive CD 4 + T Cell Activation

Yu Jin, Q. Xiu, W. Nie, 2016 .

BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis

Ji-quan Chen, Q. Xiu, Y. Zang, 2014, Tumor Biology.

A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia

Q. Xiu, Kaifeng Xu, Z. Tong, 2021, Current medical research and opinion.

Obesity survival paradox in pneumonia: a

S. Jee, Q. Xiu, K. Jung, 2014 .

Obesity survival paradox in pneumonia: a meta-analysis

S. Jee, Q. Xiu, K. Jung, 2014, BMC Medicine.

Nicotine gum or patch treatment for smoking cessation and smoking reduction: a multi-centre study in Chinese physicians

Qing Li, C. Bai, N. Zhong, 2014, Frontiers of Medicine.

[An experimental study on the mini pig model of obstructive sleep apnea syndrome].

Q. Xiu, Hongyu Yu, Jun Shen, 2005, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi.

Cyclooxygenase-2 induction requires activation of nuclear factor of activated T-cells in Beas-2B cells after vanadium exposure and plays an anti-apoptotic role.

Hao Tang, Yu Sun, Q. Xiu, 2007, Archives of biochemistry and biophysics.

B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.

Yu Jin, Q. Xiu, W. Nie, 2016, Iranian journal of immunology : IJI.

Interleukin-13 +1923C/T Polymorphism Is Associated with Asthma Risk: A Meta-Analysis

Q. Xiu, W. Nie, Yong-an Liu, 2013, BioMed research international.

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC).

Y. Luo, Q. Xiu, Yan Zhang, 2013, Annals of Oncology.

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

Ying Cheng, B. Han, He-long Zhang, 2016, BMC Cancer.

Y. Luo, Q. Xiu, Shucai Zhang, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer.

Q. Xiu, Xiao-hong Fan, 2015, Journal of Cancer Research and Therapeutics.